People | January 05, 2022
Dr. K.V.S Ram Rao is the new JMD & CEO of Granules India
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
Sucharita brings with her a rich and varied experience of two decades in Information Technology and Financial Services
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
The drug has been granted permission by DCGI for emergency use as an adjunct therapy for Covid-19
Acetaminophen extended-release tablets 650 mg is bioequivalent of the reference listed drug Tylenol
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The company posted net profit of Rs.111.44 crores for the period ended June 30, 2020.
ranules now has a total of 38 ANDA approvals from US FDA.
Granules now has a total of 37 ANDA approvals from US FDA (36 Final approvals and 1 tentative approvals).
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Subscribe To Our Newsletter & Stay Updated
